These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3027 related articles for article (PubMed ID: 28202367)

  • 1. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
    Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
    J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles: translational challenges and opportunities.
    Clemmens H; Lambert DW
    Biochem Soc Trans; 2018 Oct; 46(5):1073-1082. PubMed ID: 30242120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular communication by extracellular vesicles and their microRNAs in asthma.
    Fujita Y; Yoshioka Y; Ito S; Araya J; Kuwano K; Ochiya T
    Clin Ther; 2014 Jun; 36(6):873-81. PubMed ID: 24909737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes: Natural Carriers for siRNA Delivery.
    Kumar L; Verma S; Vaidya B; Gupta V
    Curr Pharm Des; 2015; 21(31):4556-65. PubMed ID: 26486142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of exosome surface display technology in living human cells.
    Stickney Z; Losacco J; McDevitt S; Zhang Z; Lu B
    Biochem Biophys Res Commun; 2016 Mar; 472(1):53-9. PubMed ID: 26902116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes as novel bio-carriers for gene and drug delivery.
    Jiang XC; Gao JQ
    Int J Pharm; 2017 Apr; 521(1-2):167-175. PubMed ID: 28216464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of extracellular vesicles: clinical promise and open questions.
    György B; Hung ME; Breakefield XO; Leonard JN
    Annu Rev Pharmacol Toxicol; 2015; 55():439-464. PubMed ID: 25292428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics.
    Tenchov R; Sasso JM; Wang X; Liaw WS; Chen CA; Zhou QA
    ACS Nano; 2022 Nov; 16(11):17802-17846. PubMed ID: 36354238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes as nano-theranostic delivery platforms for gene therapy.
    Tan A; Rajadas J; Seifalian AM
    Adv Drug Deliv Rev; 2013 Mar; 65(3):357-67. PubMed ID: 22820532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular RNAs as potential biomarkers for cancer.
    Happel C; Ganguly A; Tagle DA
    J Cancer Metastasis Treat; 2020; 6():. PubMed ID: 33490601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles: masters of intercellular communication and potential clinical interventions.
    Pitt JM; Kroemer G; Zitvogel L
    J Clin Invest; 2016 Apr; 126(4):1139-43. PubMed ID: 27035805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
    Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 152.